Publikationen
Studie in Science Immunology
04 March 2021: Finden Sie hier unsere neuesten Resultate über Mutationen von SARS-CoV-2 innerhalb von MHC-Klasse-I restringierten Epitope und die daraus resultierende reduzierte CD8+ T-Zellen Reaktion von Agerer et al., in Science Immunology.
Studie in Science Translational Medicine
23 November 2020: Unsere Studie, von Popa, Genger et al., über die genetisch-epidemiologische Aufschlüsselung von Superspreader-Ereignissen in Österreich und die daraus gewonnen Erkenntnisse über Mutationsdynamik und Übertragungseigenschaften von SARS-CoV-2 wird in Science Translational Medicine veröffentlicht.
Publikationsliste
- Cutaneous manifestations of SARS-CoV-2: A 2-center, prospective, case-controlled study. Unterluggauer L, Pospischil I, Krall C, Saluzzo S, Kimeswenger S, Karolyi M, Wenisch C, Lamprecht B, Guenova E, Winkler S, Viczenczova C, Bergthaler A, Weninger W, Hoetzenecker W, Stary G. J Am Acad Dermatol. 2021 Jul;85(1):202-204. doi: 10.1016/j.jaad.2021.03.064. Epub 2021 Mar 23. PMID: 33771589 Free PMC article.
- The versatility of external quality assessment for the surveillance of laboratory and in vitro diagnostic performance: SARS-CoV-2 viral genome detection in Austria.
Buchta C, Camp JV, Jovanovic J, Chiba P, Puchhammer-Stöckl E, Mayerhofer M, Plicka H, Lercher A, Popa AM, Endler L, Bergthaler A, Huf W, Benka B, Delatour V, Müller MM, Griesmacher A, Aberle SW, Görzer I. Clin Chem Lab Med. 2021 Jun 29. doi: 10.1515/cclm-2021-0604. Online ahead of print. PMID: 34187131 - SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses. Agerer B*, Koblischke M*, Gudipati V*, Montaño-Gutierrez LF, Smyth M, Popa A, Genger JW, Endler L, Florian DM, Mühlgrabner V, Graninger M, Aberle SW, Husa AM, Shaw LE, Lercher A, Gattinger P, Torralba-Gombau R, Trapin D, Penz T, Barreca D, Fae I, Wenda S, Traugott M, Walder G, Pickl WF, Thiel V, Allerberger F, Stockinger H, Puchhammer-Stöckl E, Weninger W, Fischer G, Hoepler W, Pawelka E, Zoufaly A, Valenta R, Bock C, Paster W, Geyeregger R, Farlik M, Halbritter F, Huppa JB**, Aberle JH**, Bergthaler A**. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses. Science Immunology. 2021 Mar 4;6(57):eabg6461. doi: 10.1126/sciimmunol.abg6461. PMID: 33664060.
- Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Popa A*, Genger JW*, Nicholson MD, Penz T, Schmid D, Aberle SW, Agerer B, Lercher A, Endler L, Colaço H, Smyth M, Schuster M, Grau ML, Martínez-Jiménez F, Pich O, Borena W, Pawelka E, Keszei Z, Senekowitsch M, Laine J, Aberle JH, Redlberger-Fritz M, Karolyi M, Zoufaly A, Maritschnik S, Borkovec M, Hufnagl P, Nairz M, Weiss G, Wolfinger MT, von Laer D, Superti-Furga G, Lopez-Bigas N, Puchhammer-Stöckl E, Allerberger F, Michor F, Bock C, Bergthaler A. Science Translational Medicine. 2020 Dec 9;12(573):eabe2555. doi: 10.1126/scitranslmed.abe2555. Epub 2020 Nov 23. PMID: 33229462 (Supplementary website with data and scripts)
- Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity. Koblischke M, Traugott MT, Medits I, Spitzer FS, Zoufaly A, Weseslindtner L, Simonitsch C, Seitz T, Hoepler W, Puchhammer-Stöckl E, Aberle SW, Födinger M, Bergthaler A, Kundi M, Heinz FX, Stiasny K, Aberle JH. Frontiers in Medicine. 2020 Nov 11;7:592629. doi: 10.3389/fmed.2020.592629. eCollection 2020. PMID: 33262993
- Human recombinant soluble ACE2 in severe COVID-19. Zoufaly A, Poglitsch M, Aberle JH, Hoepler W, Seitz T, Traugott M, Grieb A, Pawelka E, Laferl H, Wenisch C, Neuhold S, Haider D, Stiasny K, Bergthaler A, Puchhammer-Stoeckl E, Mirazimi A, Montserrat N, Zhang H, Slutsky AS, Penninger JM. Lancet Respiratory Medicine. 2020 Nov;8(11):1154-1158. doi: 10.1016/S2213-2600(20)30418-5. Epub 2020 Sep 24.PMID: 33131609
- Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020. Alm E, Broberg EK, Connor T, Hodcroft EB, Komissarov AB, Maurer-Stroh S, Melidou A, Neher RA, O’Toole Á, Pereyaslov D; WHO European Region sequencing laboratories and GISAID EpiCoV group. Euro Surveillance. 2020 Aug;25(32):2001410. doi: 10.2807/1560-7917.ES.2020.25.32.2001410.PMID: 32794443
- Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies. Hasan Ali O, Bomze D, Risch L, Brugger SD, Paprotny M, Weber M, Thiel S, Kern L, Albrich WC, Kohler P, Kahlert CR, Vernazza P, Bühler PK, Schüpbach RA, Gómez-Mejia A, Popa AM, Bergthaler A, Penninger JM, Flatz L. Clinical Infectious Diseases. 2020 Sep 30:ciaa1496. doi: 10.1093/cid/ciaa1496. Online ahead of print.PMID: 32997739
- Emergence of coronavirus disease 2019 (COVID-19) in Austria. Kreidl P, Schmid D, Maritschnik S, Richter L, Borena W, Genger JW, Popa A, Penz T, Bock C, Bergthaler A, Allerberger F. Wiener Klinische Wochenschrift. 2020 Aug 20:1-8. doi: 10.1007/s00508-020-01723-9. PMID: 32816114
- Mutational dynamics and transmission properties of SARS-CoV-2 superspreading events in Austria. Popa A*, Genger JW*, Nicholson M, Penz T, Schmid S, Aberle SW, Agerer B, Lercher A, Endler L, Colaço H, Smyth M, Schuster M, Grau M, Martinez, Pich O, Borena W, Pawelka E, Keszei Z, Senekowitsch M, Laine J, Aberle JH, Redlberger-Fritz M, Karolyi M, Zoufaly A, Maritschnik S, Borkovec M, Hufnagl P, Nairz M, Weiss G, Wolfinger MT, von Laer D, Superti-Furga G, Lopez-Bigas N, Puchhammer-Stöckl E, Allerberger F, Michor F, Bock C, Bergthaler A.2020 Jul. bioRxiv (https://doi.org/10.1101/2020.07.15.204339)